Αποτελέσματα Αναζήτησης
Download Medicare Reimbursement Guide. If you have questions related to Cardiolite ® reimbursement, please call (800) 362-2668 (Option 3) or email reimbursement@lantheus.com. Lantheus cannot guarantee coverage or payment for products or procedures.
- Two Day Stress/Rest
Two Day Stress/Rest - Reimbursement - Cardiolite
- Risk Stratification
§The indications for Cardiolite ® are not specific to...
- Imaging Protocols
Imaging Protocols. Suggested Cardiolite ® One-Day...
- Prescribing Information
Prescribing Information - Reimbursement - Cardiolite
- Perfusion and Function
Myocardial Perfusion and Function assessed by a Gated...
- Patients
Patients - Reimbursement - Cardiolite
- Two Day Stress/Rest
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
16 Δεκ 2021 · Clinicians and coders should review the new introductory language in the Cardiac Catheterization section to understand these changes. Other new cardiovascular codes of note include 33370 for cerebral embolic protection (placement and removal) to use with TAVR codes.
Billing for the radiopharmaceutical agents: Radiopharmaceuticals are available in unit dose or in bulk doses, the latter requiring preparation at the imaging center. Use of radiopharmaceuticals is regulated by the Nuclear Regulatory Commission (NRC) under strict procedures and guidelines.
CARDIOLITE® is a myocardial perfusion agent indicated for: • detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects)
CARDIOLITE® is a myocardial perfusion agent indicated for: detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects) evaluating myocardial function and developing information for use in patient management decisions.
Myocardial Imaging: Cardiolite ® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), is a myocardial perfusion agent that is indicated for detecting coronary artery disease by localizing myocardial ischemia (reversible defects) and infarction (non-reversible defects), in evaluating myocardial function and developing ...
